Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Assessing the Assisted Six-Minute Cycling Test as a Measure of Endurance in Non-Ambulatory Patients with Spinal Muscular Atrophy (SMA). | J Clin Med | 2023 | 38137651 | PubTator, text mining | PubMed |
| Structured Light Plethysmography for Non-Invasive Assessment of Respiratory Pattern in Spinal Muscular Atrophy Type 1. | J Clin Med | 2023 | 38137621 | PubTator, text mining | PubMed |
| Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan. | Genes (Basel) | 2023 | 38137033 | PubTator, text mining | PubMed |
| Real-Time PCR-Based Screening for Homozygous SMN2 Deletion Using Residual Dried Blood Spots. | Genes (Basel) | 2023 | 38136980 | PubTator, text mining | PubMed |
| Pain in Children and Adolescents with Spinal Muscular Atrophy: A Longitudinal Study from a Patient Registry. | Children (Basel) | 2023 | 38136082 | PubTator, text mining | PubMed |
| Newborn Genetic Screening-Still a Role for Sanger Sequencing in the Era of NGS. | Int J Neonatal Screen | 2023 | 38132826 | PubTator, text mining | PubMed |
| Benchmarking splice variant prediction algorithms using massively parallel splicing assays. | Genome Biol | 2023 | 38129864 | PubTator, text mining | PubMed |
| Efficient generation of a self-organizing neuromuscular junction model from human pluripotent stem cells. | Nat Commun | 2023 | 38114482 | PubTator, text mining | PubMed |
| Study on the efficacy, safety, and biomarkers of nusinersen in type II and III spinal muscular atrophy in children. | Front Pediatr | 2023 | 38111627 | PubTator, text mining | PubMed |
| Pregnancy in a Patient with Spinal Muscular Atrophy and Severe Restrictive Lung Disease. | AJP Rep | 2023 | 38106965 | PubTator, text mining | PubMed |
| Efficacy and safety of salbutamol in treatment of children with later-onset spinal muscular atrophy. | Zhejiang Da Xue Xue Bao Yi Xue Ban | 2023 | 38105669 | PubTator, text mining | PubMed |
| Neonatal screening for spinal muscular atrophy: A pilot study in Brazil. | Genet Mol Biol | 2023 | 38091267 | PubTator, text mining | PubMed |
| Proposal of a new clinical protocol for evaluating fatigability in adult SMA patients. | Acta Myol | 2023 | 38090548 | PubTator, text mining | PubMed |
| Sequential treatment with nusinersen, Zolgensma® and risdiplam in a paediatric patient with spinal muscular atrophytype 1: a case report. | Acta Myol | 2023 | 38090542 | PubTator, text mining | PubMed |
| Antisense oligonucleotides: a novel Frontier in pharmacological strategy. | Front Pharmacol | 2023 | 38044945 | PubTator, text mining | PubMed |
| High-sensitive cardiac troponin I (hs-cTnI) concentrations in newborns diagnosed with spinal muscular atrophy. | Front Pediatr | 2023 | 38034835 | PubTator, text mining | PubMed |
| Using the structural diversity of RNA: protein interfaces to selectively target RNA with small molecules in cells: methods and perspectives. | Front Mol Biosci | 2023 | 38033386 | PubTator, text mining | PubMed |
| Unilateral interlaminar fenestration on the convex side provides a reliable access for intrathecal administration of nusinersen in spinal muscular atrophy: a retrospective study. | Orphanet J Rare Dis | 2023 | 38031122 | PubTator, text mining | PubMed |
| Variation in Medicaid and commercial coverage of cell and gene therapies. | Health Policy Open | 2023 | 38023441 | PubTator, text mining | PubMed |
| Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era. | Front Neurol | 2023 | 38020652 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=20